Jackson Acquisition Company II (JACS.U) Prices $200M IPO

Jackson Acquisition Company II (NYSE:JACS.U) announced the pricing of its $200 million IPO and its units are expected to begin trading on the NYSE under the symbol “JACS.U”, Tuesday, December 10 2024.

The new SPAC intends to search for a healthcare target that can benefit from its team’s relationships within the healthcare services space nationally.

Jackson II’s sponsor team is led by Chief Executive Officer and Director Richard L. Jackson and Chief Financial Officer David Lawrence. Brian A. McCarthy, J. Nicholas Ayers, Stephan S. Rodgers, and Paul G. Gabos will serve on its Board of Directors.

Total SPAC deal count for 2024 year-to-date is now 53. This offering is expected to close on Wednesday, December 11, 2024.

Roth Capital Partners is acting as the sole book running manager for the initial public offering. Nelson Mullins Riley & Scarborough LLP is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Transfer & Trust Company is acting as trustee.